High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice.
about
Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID miceHumanized hemato-lymphoid system miceStudies of retroviral infection in humanized miceHumanized mice: novel model for studying mechanisms of human immune-based therapiesRecent developments in human immunodeficiency virus-1 latency researchDevelopment of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge.Creation of an immunodeficient HLA-transgenic mouse (HUMAMICE) and functional validation of human immunity after transfer of HLA-matched human cells.Human allograft rejection in humanized mice: a historical perspectiveParameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells.Human hemato-lymphoid system mice: current use and future potential for medicine.Bone marrow mesenchymal stem cells for improving hematopoietic function: an in vitro and in vivo model. Part 2: Effect on bone marrow microenvironment.Immune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID miceSCID mouse models of human stem cell engraftment.Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.Creation of "humanized" mice to study human immunityReconstitution of huPBL-NSG mice with donor-matched dendritic cells enables antigen-specific T-cell activation.The NOD/SCID chimeric mouse model of human B cell development: studies on the VH4 family immunoglobulin repertoire and implications for SLE.Human cancer growth and therapy in immunodeficient mouse models.Breaking the species barrier: use of SCID mouse-human chimeras for the study of human infectious diseases.Immunological characterization of human vaginal xenografts in immunocompromised mice: development of a small animal model for the study of human immunodeficiency virus-1 infection.Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 disease.Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.In vivo expansion of co-transplanted T cells impacts on tumor re-initiating activity of human acute myeloid leukemia in NSG miceCan humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders?Overcoming current limitations in humanized mouse researchPotent activity of a nucleoside reverse transcriptase inhibitor, 4'-ethynyl-2-fluoro-2'-deoxyadenosine, against human immunodeficiency virus type 1 infection in a model using human peripheral blood mononuclear cell-transplanted NOD/SCID Janus kinaseThe utilization of humanized mouse models for the study of human retroviral infections.Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model.Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells.HIV-1 immunopathogenesis in humanized mouse models.Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34(+) cells.Animal models on HTLV-1 and related viruses: what did we learn?Development of Humanized Mice in the Age of Genome Editing.Mouse models for pre-clinical drug testing in leukemia.Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells.Modeling Natural Killer Cell Targeted Immunotherapies.Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
P2860
Q24531320-C1718521-9BF0-45D4-B633-DD3355BAFDEDQ26771440-8F668CC6-6691-4F6E-B427-7840F5C5C457Q26849806-72AC2A91-9A15-4E52-AF15-943BB9FC5DF6Q26996648-0416E1DB-772C-45C5-9EAF-243FF808C511Q27013114-99D2E031-5ABC-4421-B245-E782E0B48336Q33520247-954651C4-9FB9-4064-B288-D098E1BC9679Q33553918-F8DF97FE-8A02-4C1F-9A31-0E8866CB57DCQ33577374-C18755CA-D273-4A84-BC83-480149481F5FQ33716675-74481317-1AD9-4AD4-9D9F-C6C8C67D4699Q33911359-22231A4B-C4AA-451D-B90D-D9E661645C5CQ33995307-B847E1B2-F3D6-4DBE-A2AD-AEC47B0A811BQ34058486-01CA4E3A-FE3C-40A9-A3D0-557D799EB123Q34141837-EA2346E1-55B7-42D4-81E8-A6A0C2749E55Q34470843-51D7F06C-60D3-40C4-9A4B-1E2F96879A5AQ34474320-F314B43B-B409-433E-851B-2124DE2F3BD1Q34501933-E542D5D1-08C4-49BE-986F-49E55EAD8E91Q34525894-2538013F-DA4A-4B16-BF1B-57B246CE5B35Q35112331-16017080-40B9-47C3-906D-BF3485067EBAQ35545282-A73870A8-ACBE-4627-B80A-10E1A895327FQ35594398-D98B6E30-6C60-45AF-AF78-37ECBBB2A23FQ35747109-AAB6F4CC-B56B-4819-B396-23E0EEE79975Q36111849-B357DCB8-823F-4DB8-987C-CA1DAC160511Q36279270-0F4BFC8B-165B-44DD-8872-D9409290D494Q36453843-F61455FE-251F-4EC3-B0D7-2C71735EB3D8Q36753942-5DECD2B4-CC7E-4754-A2CF-928D8525E21CQ37195155-EB517C63-75AD-4B1B-8846-70F835FE6501Q37254483-D6FC3538-A76D-48DD-9835-2BBA3C2723BDQ37333100-A4FA76E6-AE93-4306-AC82-4B1601FDA26CQ37346027-B5436E20-5563-4534-B32B-D957B946F9BFQ37365361-6F0DFEFB-6E46-48A0-B58B-C8B7C457A3F4Q37608438-6A40A67B-B1D0-4CC0-A44C-F9A34819542FQ37676228-331BEDB0-E4B5-42A5-BB38-C413C12BC3F1Q37737987-BC7CF52B-BCF9-4B8D-9D47-9434601C1D7CQ37981545-8D511BA7-0103-466B-9FBE-5AF52C29B652Q38050763-D8082009-AFB4-4BFE-854A-968D28E3F977Q38884521-3625AE6C-1D62-4F87-BA95-76BA208B2146Q38937610-B4E2664A-8F50-4D48-83C4-28884F4AF447Q39213703-152B9337-CF95-48DF-85C0-6F271FF44801Q39239278-4B7C0AB1-8696-4842-B848-74DAD891C377Q39878783-13217865-B6BC-4A5B-9C96-A361B7CCA6D9
P2860
High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
High levels of human periphera ...... on in NOD/LtSz-scid/scid mice.
@en
High levels of human periphera ...... on in NOD/LtSz-scid/scid mice.
@nl
type
label
High levels of human periphera ...... on in NOD/LtSz-scid/scid mice.
@en
High levels of human periphera ...... on in NOD/LtSz-scid/scid mice.
@nl
prefLabel
High levels of human periphera ...... on in NOD/LtSz-scid/scid mice.
@en
High levels of human periphera ...... on in NOD/LtSz-scid/scid mice.
@nl
P2093
P356
P1476
High levels of human periphera ...... on in NOD/LtSz-scid/scid mice.
@en
P2093
Greiner DL
Hesselton RM
Sullivan JL
P304
P356
10.1093/INFDIS/172.4.974
P407
P577
1995-10-01T00:00:00Z